Correlation between OPN and P21 in non-small cell lung cancer

Chinese Journal of Lung Cancer

Volumn 10, Issue 4, 2007, Pages 288-290

  Zhang, Xuelin ^a   Xue, Song ^a   Zheng, Jia Hao ^a   Liu, Sha ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Immunohistochemistry; Non small cell lung cancer; OPN; P21

Indexed keywords

OSTEOPONTIN; PROTEIN P21;

ARTICLE; CANCER RISK; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LUNG PSEUDOTUMOR; LYMPH NODE METASTASIS; PROTEIN EXPRESSION;

EID: 34548707848     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Rangaswami H, Bulbule A, Kundu GC. Osteopontin: role in cell signaling and cancer progression. Trends Cell Biol,2006,16(2) : 79-87.
2. Shijubo N, Uede T, Kon S, et al. Vascular endothelial growth factor and osteopontin in stage I lung adenocarcinoma. Am J Respir Crit Care Med,1999,160(4) : 1269-1273.
3. Zhang J, Takahashi K, Takahashi F, et al. Differential osteopontin expression in lung cancer. Cancer Lett,2001,171(2) : 215-222.
4. Minamoto T, Mai M, Ronai Z. K-ras mutation: early detection in molecular diagnosis and risk assessment of colorectal, pancreas, and lung cancers - a review. Cancer Detect Prev,2000,24(1) : 1-12.
5. Przybojewska B, Rydzynski K, Stepnik M, et al. Immunohistochemical evaluation of P21ras and P53 proteins expression in human non-small-cell lung cancers. Neoplasma,2003,50(3) : 198-203.
6. Denhardt DT, Mistretta D, Chambers AF, et al. Transcriptional regulation of osteopontin and the metastatic phenotype: evidence for a Ras-activated enhancer in the human OPN promoter. Clin Exp Metastasis,2003,20(1) : 77-84.
7. Chambers AF, Behrend EI, Wilson SM, et al. Induction of expression of osteopontin (OPN; secreted phosphoprotein) in metastatic, ras-transformed NIH 3T3 cells. Anticancer Res,1992,12(1) : 43-47.
8. Wu Y, Denhardt DT, Rittling SR. Osteopontin is required for full expression of the transformed phenotype by the ras oncogene. Br J Cancer,2000,83(2) : 156-163.